Skip to main content

Broad Institute, Dana-Farber Launch Patient-Driven Prostate Cancer Project

NEW YORK (GenomeWeb) – The Broad Institute and the Dana-Farber Cancer Institute announced today that they have launched an internet-based initiative to encourage prostate cancer patients to share their medical data to help advance research into the disease.

Called the Metastatic Prostate Cancer (MPC) Project, the program allows prostate cancer patients to fill out a demographic and medical history survey on its website. Patients will then be sent a saliva-collection kit — and in some cases a blood biopsy kit, as well — to provide MPC researchers with samples for DNA sequencing. The patient and tumor DNA data will be integrated and de-identified, and then made available to researchers worldwide via a web portal.

"To answer many important questions about metastatic prostate cancer, we need to engage patients as partners," Eliezer Van Allen, a Broad associate member and Dana-Farber oncologist, said in a statement. "Together with patients, we want to create a research program that can fuel new discoveries, reveal why patients respond differently to treatments, and uncover new genetic targets so that we can help current and future generations of men."

The MPC is based on two similar efforts by Broad and Dana-Farber: the Angiosarcoma Project, which has almost 300 participants, and the Metastatic Breast Cancer (MBC) Project, which includes more than 4,300 participants and released its first genomic and phenotypic data set late last year.

"We come into this project with a track record," Van Allen added. "We can point men with advanced prostate cancer to the exciting work that's being done with patients in these other programs to underscore the power of this partnership."

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.